Mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex] — RxCUI 1797870
RxNorm drug concept · Semantic branded drug
RxCUI 1797870
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
7 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1797870
Official nameMometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNasonex 50 MCG/ACTUAT Metered Dose Nasal Spray; Nasonex 0.05 MG/ACTUAT Metered Dose Nasal Spray
FDA products mapped2
Package NDCs mapped7
Reported Medicaid activity (SDUD)1,115 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Mometasone Nasal Spray: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You might start to notice some relief within 12 hours of your first dose, but the full effect usually kicks in after several days of using it regularly, once a day. It works best w...
- How long does it take for this spray to start working?
- Yes, it's designed for daily use, and for most people it's well tolerated over the long term at the recommended dose. That said, your doctor should check your nasal passages period...
- Is it okay to use this spray every day long-term?
🕸️ Concept Web — How Mometasone furoate 0.05 MG/ACTUAT Metered Dose N... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]
RxCUI 1797870 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Mometasone
108118IN -
Mometasone furoate
30145PIN
-
Mometasone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Nasonex
153376BN
-
Nasonex
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Mometasone Metered Dose Nasal Spray
1797864SCDF -
Mometasone furoate Metered Dose Nasal Spray
2648050SCDFP -
Mometasone Inhalant Product
1165391SCDG -
Mometasone Nasal Product
1165392SCDG -
Mometasone furoate Inhalant Product
2659487SCDGP -
Mometasone furoate Nasal Product
2661310SCDGP -
Mometasone Metered Dose Nasal Spray [Nasonex]
1797868SBDF -
Mometasone furoate Metered Dose Nasal Spray [Nasonex]
2656347SBDFP - +5 more in this family
-
Mometasone Metered Dose Nasal Spray
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray
1797865SCD -
Mometasone furoate 0.05 MG/ACTUAT
358793SCDC -
Mometasone furoate 0.05 MG/ACTUAT [Nasonex]
565252SBDC
-
Mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray
SCD · 1797865 -
Mometasone furoate 0.05 MG/ACTUAT
SCDC · 358793 -
Mometasone Metered Dose Nasal Spray
SCDF · 1797864 -
Mometasone furoate Metered Dose Nasal Spray
SCDFP · 2648050 -
Mometasone Inhalant Product
SCDG · 1165391 -
Mometasone Nasal Product
SCDG · 1165392 -
Mometasone furoate Inhalant Product
SCDGP · 2659487 -
Mometasone furoate Nasal Product
SCDGP · 2661310
Brand-Name Concepts
-
Mometasone furoate 0.05 MG/ACTUAT [Nasonex]
SBDC · 565252 -
Mometasone Metered Dose Nasal Spray [Nasonex]
SBDF · 1797868 -
Mometasone furoate Metered Dose Nasal Spray [Nasonex]
SBDFP · 2656347 -
Nasonex Inhalant Product
SBDG · 1179823 -
Nasonex Nasal Product
SBDG · 1801260 -
Nasonex
BN · 153376
📦 FDA Products & Package NDCs
2 products · 7 package NDCs
7 package NDCs map to RxCUI 1797870 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00113-1720-01 | 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-01) / 30 SPRAY, MET... | Nasonex | L. Perrigo Company | 2025-06-30 |
| 00113-1720-02 | 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-02) / 120 SPRAY, ME... | Nasonex | L. Perrigo Company | 2022-06-29 |
| 00113-1720-06 | 2 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-06) / 120 SPRAY, ME... | Nasonex | L. Perrigo Company | 2022-06-29 |
| 00113-1720-07 | 3 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-07) / 144 SPRAY, ME... | Nasonex | L. Perrigo Company | 2024-01-21 |
| 00113-1720-11 | 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1720-11) / 60 SPRAY, MET... | Nasonex | L. Perrigo Company | 2022-06-29 |
| 00113-1999-01 | 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1999-01) / 30 SPRAY, MET... | Childrens Nasonex | L. Perrigo Company | 2023-03-15 |
| 00113-1999-11 | 1 BOTTLE, SPRAY in 1 PACKAGE (0113-1999-11) / 60 SPRAY, MET... | Childrens Nasonex | L. Perrigo Company | 2023-02-07 |
Observed labelers:
L. Perrigo Company (7)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.